Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

OptimizeRx Appoints Todd Inman as Chief Technology Officer

Published

on

ROCHESTER, Mich., March 02, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, has appointed Todd Inman as chief technology officer.
Inman brings to the position more than 30 years of experience delivering outcomes across the healthcare technology industry. Since joining OptimizeRx in January 2019 as VP of Technology, he has led the company’s technology innovation teams in the U.S., Europe and Israel. Inman has overseen OptimizeRx’s establishment of a state-of-the-art AWS cloud backbone, data and analytics infrastructure, and the recently announced OptimizeRx Innovation Lab. He will continue leading the implementation and development of the company’s newly integrated communications platform.“Todd’s appointment to this new position reflects our commitment to technology innovation that improves patient-centered care, access and adherence to medications,” said Miriam Paramore, president of OptimizeRx. “Given Todd’s expertise and track record of success, he is uniquely suited to fulfill the role of chief technology officer. He recently led the successful technology integration of our newly acquired companies, and we’re looking forward to many more great things to come.”Inman commented: “I’m honored to take on this role at OptimizeRx to continue building and growing a world-class platform that creates better communication pathways within the healthcare industry. Leveraging the power of technology to streamline communication among stakeholders in the care journey is critical, and I couldn’t be more excited to contribute to that global effort with the best team in its class.”Prior to OptimizeRx, Inman has held leadership roles within prominent health technology and information services companies. While leading data solutions at a large publicly traded health IT company, Inman directed the design and implementation of the company’s big data strategy. This resulted in an AWS cloud-based data asset of over 30 billion digital health records for 230 million patients. With this highly secured and compliant health information asset, he led artificial intelligence, machine learning, and business intelligence efforts that resulted in the creation of numerous solutions benefiting providers, payers, and patients.Inman and other OptimizeRx leaders will be attending HIMSS in Orlando on March 9-13, 2020, to demonstrate the industry-leading technology connecting provider and patient communications from the point-of-care and beyond. To schedule a meeting, please email [email protected].About OptimizeRx
OptimizeRx® (NASDAQ: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest digital platform connecting life sciences to the point-of-care, OptimizeRx provides a direct channel for payers, medtech companies, medical associations and pharma companies to communicate with healthcare providers right within their workflow and also directly to patients.
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications platform and digital therapeutics SaaS platform.For more information, follow the company on Twitter, LinkedIn or visit www.OptimizeRx.com.Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words ‘estimate,’ ‘possible’ and ‘seeking’ and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. 
OptimizeRx Contact 
Doug Baker, CFO 
Tel (248) 651-6568 x807 
[email protected] 
Media Relations Contact 
Maira Alejandra, Media Relations Manager
Tel (754) 245-7070
[email protected]
Investor Relations Contact 
Ron Both, CMA 
Tel (949) 432-7557 
[email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Kharon Data and Technology Selected by U.S. Department of the Treasury

Published

on

kharon-data-and-technology-selected-by-us.-department-of-the-treasury

Treasury officers will gain access to Kharon’s platform for sanctions-related risk intelligence
WASHINGTON, May 7, 2024 /PRNewswire/ — Kharon announces the signing of a contract with the U.S. Department of the Treasury. Through this engagement, officials within the Treasury Department will gain access to Kharon’s global risk analytics platform. Kharon’s insights and analytic tools are used by leading financial institutions, companies, and governments to address global security threats, and to support risk management in connection with KYC, transaction screening, sanctions evasion, investigations, and trade controls.

This award underscores Kharon’s commitment to helping organizations navigate the complexities of sanctions compliance and combatting sanctions evasion, including the OFAC and EU 50 percent rules, FinCEN alerts on Harmonized System (HS) codes and export control evasion, and countering terrorist financing.
Alongside a recent award with the U.S. Customs and Border Protection, this engagement with the Treasury Department expands the U.S. Government’s access to Kharon insights, data analytics, and investigative workflow tools for critical public sector security objectives.
Kharon’s expertise in generating data-driven insights will assist the Treasury Department with its mission of disrupting the financial operations that underpin the networks of foreign actors tied to global security threats, including terrorism, nuclear and missile proliferation, Russia’s invasion of Ukraine, human rights violators, transnational crime, corruption, and others. Kharon insights draw upon all available open-source information and are powered by world-class subject matter expertise and data analytics combined with cutting-edge AI and natural language processing (NLP) systems. Kharon has been awarded multiple patents for its transformative analytic and workflow tools that have helped leading banks and corporates minimize risk and maximize efficiency for critical compliance, investigative, and risk management functions.
“Effectively implementing sanctions and trade controls requires both public and private sector organizations to have the insights needed to counter evasion,” said Howard Mendelsohn, Kharon’s Chief Client Officer. “This award represents an additional step in aligning critical insights across the public and private sectors. We are proud to support the U.S. Department of the Treasury in its critical mission.”
About Kharon
Kharon helps leading organizations identify a wide range of sanctions and compliance risks, critical to managing financial crimes, supply chain exposure, export controls, investment risk, and more. Combining cutting-edge technology and data science with industry-leading research, our solutions provide the critical insights required for a comprehensive view of illicit finance and other commercial threats.
The Kharon leadership team includes former senior officials from the U.S. Government who have leveraged their unique expertise to build risk management solutions that are trusted by the world’s top financial institutions, global corporates, and professional services firms.
Visit Kharon.com and follow Kharon on LinkedIn to learn more.
Media Contacts [email protected]
Logo – https://mma.prnewswire.com/media/1283302/Kharon_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/kharon-data-and-technology-selected-by-us-department-of-the-treasury-302137445.html

Continue Reading

Artificial Intelligence

Imaging Endpoints Unveils New Initiative with Revolution Endpoints™, an Investment Subsidiary to Accelerate Innovation and Growth

Published

on

imaging-endpoints-unveils-new-initiative-with-revolution-endpoints™,-an-investment-subsidiary-to-accelerate-innovation-and-growth

SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire/ — Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging the Company’s strong leadership and financial position to acquire synergistic technologies and services. This initiative aims to further advance the company’s internal research programs targeted toward development of cutting-edge service offerings.

Revolution Endpoints is already meticulously evaluating emerging technologies for adoption while exploring licensing, partnership, or acquisition of the most promising and synergetic opportunities. By identifying and integrating emerging technologies that complement internal development efforts and existing services, Imaging Endpoints intends to ensure it continues to lead the industry in service offerings.
Doug Dean Burkett, CEO and President of Imaging Endpoints commented: “For fifteen years we have been relentlessly executing on a consistent, unwavering strategy to organically grow our leadership in oncology-focused imaging CRO services. We are now generally recognized as leading the industry in science and quality, and our efforts have yielded remarkable growth.  We are fortunate to be in a position to invest in emerging technologies that are synergistic with our own development projects and our vision to Connect Imaging to the Cure™. Through this new subsidiary, we are excited to explore new frontiers, support transformative ideas, and continue our mission of advancing healthcare and improving patient outcomes.”
IE believes in the power of collaboration and innovation to drive progress in the fight against cancer. Revolution Endpoints is engaging with emerging technology leaders within AI assisted image evaluation, quantitative biomarkers, big datasets, predictive analytics and NLP, 3D imaging, AR, VR, AI enhanced enterprise automation, and blockchain technology that have potential to further streamline and improve both image workflows and efficacy analysis. Service providers with synergistic technologies and service offerings may also be of interest.
For more information about Revolution Endpoints or to discuss your emerging technology with our experts, please visit Revolution Endpoints or contact us at [email protected]
About Imaging Endpoints
Imaging Endpoints (IE) is passionately focused on its vision to Connect Imaging to the Cure. With a flawless global inspection record and a 95% marketing authorization success rate, IE has a proven track record of supporting successful regulatory submissions across the globe. IE’s commitment to quality, innovation, and excellence has positioned it as the global leader in oncology imaging.
Imaging Endpoints is the largest oncology-focused Imaging CRO, with 8 offices strategically located across 6 countries including Scottsdale, AZ, Cambridge, MA; London, UK; Leiden, Netherlands; Basel, Switzerland; Hyderabad, India; and Shanghai, China.
IE is an affiliate of HonorHealth, one of the largest healthcare systems nationally, and also an affiliate of Southwest Medical Imaging, Ltd. (SMIL/RadPartners), part of the largest private radiology group in the U.S.
Media Contact
Contact No: 480.314.3070
Photo: https://mma.prnewswire.com/media/2405411/Imaging_Endpoints_Revolution.jpgLogo: https://mma.prnewswire.com/media/2405461/Imaging_Endpoints_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/imaging-endpoints-unveils-new-initiative-with-revolution-endpoints-an-investment-subsidiary-to-accelerate-innovation-and-growth-302138084.html

Continue Reading

Artificial Intelligence

ICIS Launches Ask ICIS Generative AI Commodities Assistant

Published

on

icis-launches-ask-icis-generative-ai-commodities-assistant

Global commodities intelligence provider launches generative AI assistant to boost access to expert insights and data around the global energy and chemicals markets
LONDON, May 7, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, announced the launch of Ask ICIS, a first of its kind generative AI assistant that will enhance access to ICIS’ standout intelligence and insights for the energy and chemicals markets.

 
As commodity markets become more complex and dynamic, the need for both highly accurate and up-to-the-minute information has never been more important. Underpinned by unparalleled chemical and energy market datasets and decades of editorial expertise, Ask ICIS combines ICIS’ vast market intelligence with the power of generative AI technology.
Currently in beta, Ask ICIS is available in multiple languages and supported with citations, Ask ICIS allows customers to delve deeper, supporting timely, confident strategic decision-making with comprehensive market intelligence. 
“At ICIS, we are committed to delivering the best possible intelligence to our customers so that they can arrive at the best possible outcomes for the decisions they need to make,” said Jeff Skelton, CEO of ICIS. “Through Ask ICIS, we are taking our ambition one step further by unlocking access to our trusted and actionable insights to provide immediate and personalized responses to complex customer enquiries  in a fraction of the time. We are committed to helping our customers adopt and scale new technologies, enabling them to make better decisions and bring the maximum value possible to their organizations.”
Sourced exclusively from ICIS’ expert data and insight, Ask ICIS connects users to content tailored directly to their needs based on their role, region, and priorities. Source citations are built into every response allowing users to delve deeper and enabling more confident, timely, strategic decision-making. In addition, Ask ICIS also provides bespoke suggested prompts and follow-up questions to allow users to uncover additional insights and “unknown unknowns” to gain an unprecedented view and understanding of market events.
“To drive success in today’s commodity markets you need to have the most innovative tools and information at your disposal,” said Skelton. “We strongly believe that Ask ICIS not only helps our customers achieve new goals and levels of performance but has also sets a new bar for the way commodity markets can now access intelligence.”
For more information on ICIS please visit, www.icis.com. For more information on Ask ICIS, or if you are an ICIS customer  interested in joining the beta progam, please visit: https://www.icis.com/explore/contact/ask-icis/.
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of $78.2bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £62.4bn | €73bn | $78.2bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-launches-ask-icis-generative-ai-commodities-assistant-302135677.html

Continue Reading

Trending